Duloxetine withdrawal syndrome in a newborn. - Wikidata - awgldk - TriplyDB

Duloxetine withdrawal syndrome in a newborn.

Duloxetine withdrawal syndrome in a newborn.

http://www.wikidata.org/entity/Q43921724

about

Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.

P2860

Q30249670-50DE6CF7-29E1-44CF-B9F3-E8BEF8D47AAD Q38599005-7BA01F0A-38FB-4465-99AA-C8005A212677

P2860

Duloxetine withdrawal syndrome in a newborn.

http://www.wikidata.org/entity/Q43921724

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Duloxetine withdrawal syndrome in a newborn.

@en

Duloxetine withdrawal syndrome in a newborn.

@nl

type

label

Duloxetine withdrawal syndrome in a newborn.

@en

Duloxetine withdrawal syndrome in a newborn.

@nl

prefLabel

Duloxetine withdrawal syndrome in a newborn.

@en

Duloxetine withdrawal syndrome in a newborn.

@nl

P1433

Q43921724-AC896C65-805A-4989-A01B-60B1F5AEB63B

P1476

Q43921724-F4547234-1067-45BD-AFF2-A4D4E0005239

P2093

Q43921724-9380D7B5-20FB-4A12-A830-67F1BA43A184

P2860

Q43921724-1F029BA3-50EA-4E99-A549-527F4BC128DA

Q43921724-741B2DA4-49C8-46B2-8FC1-609D12A722C8

Q43921724-7DDBE588-E6C0-481C-8477-F594A613C93A

Q43921724-7DF117D4-1A77-4F96-916B-C39C43E54763

Q43921724-807D1DB2-2956-452B-BF4F-DFC3DF2CBEB2

Q43921724-9A59714C-9F68-45C7-ACB8-B92084E698BD

Q43921724-FD4576AD-212D-4EFE-B442-8E9442B1A929

P304

Q43921724-A3FDE6D8-2073-4E15-B48B-D81398DA1A89

P31

Q43921724-1BAC7D39-9863-4395-A999-7969295A6331

P356

Q43921724-B87CB8F9-7B1C-4F1B-A62D-59BAAB9CF96B

P433

Q43921724-A1F7A523-F472-45B3-995C-4D55AD11D14B

P478

Q43921724-440405E3-E3D1-47C1-858A-D18A63FBB330

P50

Q43921724-A732C0C2-5A13-4F63-9FF2-FA022E1CAB37

P577

Q43921724-FE640307-8488-4F71-84D7-AA1C696FA4A5

P698

Q43921724-CCBA37FF-7AEF-49EB-B51A-534D1FFA631D

P356

0009922812450509

P1433

Clinical Pediatrics

P1476

Duloxetine withdrawal syndrome in a newborn

@en

P2093

Nicole A Abdy

http://www.w3.org/2001/XMLSchema#string

P2860

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of N

Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy.

A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health.

Poor neonatal adaptation after in utero exposure to duloxetine.

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.

P304

976-977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0009922812450509

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly Gerhart

P577

2012-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22718702

http://www.w3.org/2001/XMLSchema#string